HIV test monitoring

Methods: Surveillance began in 1982 with AIDS case reporting, and expanded in 1984 to include laboratory reporting of HIV diagnoses. In E,W&NI clinical HIV reports collecting more detailed demographic and epidemiological were introduced in 2000 to supplement laboratory reporting. Probable route of infection is collected for all patients. Ethnic group is collected (E,W&NI), nationality in Scotland. Country of birth has been collected in E,W&NI since 2000.

Data collection: A provided form to be completed at time of HIV diagnoses, first AIDS and death and forwarded to CfI on an ongoing basis.

Coverage: Laboratories and clinicians throughout the UK.

Infection:HIV

Chlamydia testing in young adults,

Methods: The NCSP began in April 2003 and offers opportunistic screening to all sexually active women and men, aged under 25. Demographic, behavioural and clinical data is collected including sex, age, ethnicity, specimen type, test type, clinical setting and information regarding sexual history on a quarterly basis. Information on patient management and partner follow up is collected on an annual basis.

Data collection: Pro-active opportunistic screening outside of GUM setting triggers ongoing report to CfI

Coverage: Health (e.g. GPs & CCS) and non-health care (e.g. universities and prisons) settings outside of GUM clinics in England. The NCSP currently covers 25% of PCTs.

Infection: Chlamydia testing

 

Hepatitis B vaccine uptake in prisoners

Methods: Monitoring of hepatitis B vaccination in prisons began in 2003 with a 22 prison pilot. Enrolment of prisons into the monitoring has increased and currently 128 of 143 establishments report to the HPA Prison Infection Prevention Team on a monthly basis. In 2007 hepatitis B vaccination became a mandatory activity in prisons nationally, and the monitoring data are being used to performance-manage prisons. The exact variables and definitions are still being determined.

Data collection: Monthly returns to the HPA Prison Infection Prevention Team. As of June 2007, 71 prisons were sending paper returns and 57 were reporting electronically. All new prisons joining the programme are being enrolled electronically where feasible. Remaining prisons reporting on paper are being switched over where possible.

Coverage: As of June 2007, 128 of 143 establishments were enrolled on the monitoring programme. This figure is set to rise as implementing the programme and reporting has become a mandatory Key Performance Indicator.

Infection: Hepatitis B vaccine

 

Hepatitis B vaccine uptake among gay male GUM clinic attendees

Methods: The HepB3 survey monitors the uptake of hepatitis B vaccination among MSM attending GUM clinics as first time attendees. Reasons for nonvaccination at dose 1 are collected so that only patients that are eligible for vaccination are included in the denominator (used to calculate dose coverage and course adherence rates).

Data collection: A provided form to be completed for all new homo/bisexual male patients attending  GUM clinic and forwarded to CfI on an ongoing basis

Coverage: GUM clinics throughout England. Participation is not mandatory but the response rate has exceeded 80% since the survey was implemented in 2003.

Infection: Hepatitis B vaccine

 

Ante-natal screening for infections at national level

Methods: Data on offer, acceptance and result of an antenatal test for hepatitis B, HIV, syphilis and rubella immunity are collected at the maternity unit level in aggregate form. Data are labelled as being derived from maternity unit records, laboratory records (termed proxy data), combination records, or unknown/other sources. At CfI the data are standardised and validated and national tables of results produced. Maternity units can also be followed up to complete missing information.

Data collection: Data are collected by regional antenatal screening co-ordinators from the maternity units and forwarded to regional units. Nationally these data are collated at CfI.

Coverage: Engagement with all pregnant women at antenatal clinics reported six monthly either directly to CfI or via regional collection.

Infection: Ante-natal infection testing.